SetPoint Medical has a breakthrough device designation for its neuroimmune modulation device for the treatment of relapsing-remitting multiple sclerosis (RRMS). This is the second breakthrough ...
Trial assesses proprietary new device that delivers doses of electricity to treat rheumatoid arthritis; builds on first-in-human data SetPoint Medical, a clinical-stage biomedical technology ...
Investigators looking into the Givaudan Sense Colour plant in Louisville released a report on Thursday of the events leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback